|
aquascoot
|
and industrial agriculture industries pouring into public universities, and the corrosive effect all that money is having on the independence of science. Evidence suggests that biotech industry influence is a pervasive problem, corrupting science and distorting public discussion. It extends much farther than the specific examples provided by the New York Times article. As with the climate change debate, where a powerful fossil fuel industry is slowing response to an environmental and social disaster, the biotech industry and industrial agriculture more broadly is delaying choices that would move us toward an urgently needed sustainable and just food and agriculture system.
The emails linked to the New York Times article also reveals some of the many other academic scientists, who have vocally supported biotech or panned biotech critics, and were copied on industry emails. We should not implicate scientists in greenwashing or collusion with the biotech industry simply for being copied on emails, or even some communication with companies. It is not clear from these emails whether those other scientists have also engaged in collaboration with the industry, or accepted industry money. But the efforts of many of these scientists to vigorously defend biotechnology or even attack critics have been documented elsewhere.
There is no reason to think this money buys less influence in academia than the widely recognized corrupting influence that money has on politics. Unlike academic science though, no one has illusions that our political process is objective. The perceived objectivity of academic scientists presents a huge opportunity for the biotech industry to influence public opinion in ways it could not accomplish otherwise.
A Tangled Web
Since the NYT article was published, several of these scientists have doubled down, saying that they have been proud to serve a cause they believe in. And I have no reason to doubt their sincerity. These scientists are effective in their spokesperson roles in part because of their backgrounds in molecular biology, the deep interest in which preceded their involvement with the ag biotech industry.
But this misses the point, which is that the collaboration with industry, its public relations machines, such as Ketchum, and access to industry dollars, allows these scientists to amplify their voices with the journalists and the media, the public, and policymakers way beyond what could otherwise occur.
As one small example, Bruce Chassy, an emeritus professor at the University of Illinois, bemoans the challenges of flying economy class (all he can afford, he says) to participate as an invited speaker at a biotech conference in New Delhi. He strongly implies he would not endure such tribulations, and would skip the meeting without industry support. In an August 29, 2011 email to Eric Sachs of Monsanto, he suggests that the ag industry trade group CropLife, of which Monsanto and other biotech companies are members, pay his way (Chassy was listed as a speaker at the event). In a separate email, Monsanto’s Sachs also suggests to Chassy that he participate in an American Medical Association meeting to try to dissuade the AMA from supporting mandatory labeling of GE foods.
That academic scientists recognize the value of their perceived independence is suggested in an email from University of Florida Scientist Kevin Folta to Monsanto’s Keith Reding, Regulatory Policy Lead, on April 17, 2013: “keep me in mind if you ever need a good public interface with no corporate ties. That knows the subject inside out and can think on his feet [emphasis added].”
In another example from the NYT article, Dow reminds David Shaw, a Mississippi State University weed scientist, of its generosity. And an email to Shaw on Jan 17, 2012 from John Jachetta, Government affairs leader at Dow AgroSciences, urges Shaw to submit comments to the United States Department of Agriculture (USDA) to approve Dow’s Enlist soybeans, and provides three pages of helpful suggestions about topics and arguments. The Enlist crops are resistant to glyphosate and 2,4-D herbicides, and are the industry’s response to the epidemic of glyphosate resistant weeds caused by the first generation of glyphosate resistant crops. This strategy has been criticized as futile and one that will lead to greatly increased herbicide use and more herbicide resistance.
In a February 20, 2012 email from Shaw back to Jachetta, Shaw supplies his draft comments and asks for feedback from Dow.
In several emails in the spring of 2013, John Sorteres of Monsanto coordinates activities with both Shaw and, apparently, Prof. Mike Owen, a weed scientist at Iowa State University, on how to counter public comments to APHIS that argue against approval of Monsanto’s dicamba resistant crops, including detailed arguments and analyses. Dicamba is an herbicide similar to 2,4-D.
An August 30, 2013 email from Mississippi State acknowledges unrestricted gifts from Monsanto to Dr. Shaw and four other faculty members.
|
Forum
Pages: 1
The Thing About the Joe Rogan Experience... (Read 2377 times)
